T. Rowe Price
Portfolio in United States: 2 funded startups tracked by Uback, 2 of them in a ranking.
Portfolio on Uback2startups, 1 country
In a ranking2ranked by AI-estimated valuation
On the Radar0eligible, not ranked
Latest deal trackedSep 2024ArsenalBio
Portfolio on Uback
Sorted by Uback rank, then Radar by last round| Company | Uback | Sector | Round backed | Valuation (AI) |
|---|---|---|---|---|
| ArsenalBio | #4 Gene & cell therapies | Healthtech › Biotech › Gene & cell therapies | Series C · USD 325M · Sep 2024 | Unicorn |
| GOAT Group | #5 Second-hand | Commerce & consumer › E-commerce › Second-hand | Series F · USD 195M · Jun 2021 | Unicorn |
Only startups that meet Uback’s eligibility rules are shown. Amounts are round sizes, not the fund’s share. Rounds as reported by public sources.
By sector
Deals tracked per year
12021
02022
02023
12024
Co-investors
ARCH Venture Partners · Regeneron · NVIDIA · Bristol Myers Squibb · SoftBank Vision Fund · Park West · Franklin Templeton
Investors that joined the same rounds, as reported by public sources.
Sources. arsenalbio.com, biopharmadive.com, en.wikipedia.org, forgeglobal.com, prnewswire.com, as cited on each company’s profile.
Last updated: Oct 2026Report a missing dealReport an error
Uback is a content publisher. It provides no investment advice, receives no mandate and takes part in no transaction.